Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients

BACKGROUND: One of the main causes of anaemia in patients with end-stage renal disease is relative deficiency in erythropoietin production. Eythropoiesis stimulating agent (ESA), a potent haematopoietic growth factor, is used to treat anaemia in haemodialysis patients. The effect of ESA is usually a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Shun, Nakamura, Seishi, Sugiura, Tetsuro, Tsuka, Yoshiaki, Takahashi, Nobuyuki, Matsumura, Koichiro, Okumiya, Toshika, Baden, Masato, Shiojima, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666014/
https://www.ncbi.nlm.nih.gov/pubmed/34895154
http://dx.doi.org/10.1186/s12882-021-02623-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666014/
https://www.ncbi.nlm.nih.gov/pubmed/34895154
http://dx.doi.org/10.1186/s12882-021-02623-4

Ejemplares similares